Search Results - "Nelson, Robert P"

Practice parameter for the diagnosis and management of primary immunodeficiency by Bonilla, Francisco A., MD, PhD, Khan, David A., MD, Ballas, Zuhair K., MD, Chinen, Javier, MD, PhD, Frank, Michael M., MD, Hsu, Joyce T., MD, Keller, Michael, MD, Kobrynski, Lisa J., MD, Komarow, Hirsh D., MD, Mazer, Bruce, MD, Nelson, Robert P., MD, Orange, Jordan S., MD, PhD, Routes, John M., MD, Shearer, William T., MD, PhD, Sorensen, Ricardo U., MD, Verbsky, James W., MD, PhD, Bernstein, David I., MD, Blessing-Moore, Joann, MD, Lang, David, MD, Nicklas, Richard A., MD, Oppenheimer, John, MD, Portnoy, Jay M., MD, Randolph, Christopher R., MD, Schuller, Diane, MD, Spector, Sheldon L., MD, Tilles, Stephen, MD, Wallace, Dana, MD, Khan, David, MD

“…The American Academy of Allergy, Asthma & Immunology (AAAAI) and the American College of Allergy, Asthma & Immunology (ACAAI) have jointly accepted…”
Get full text

Effect of Sirolimus levels between days 11 and 20 after allogeneic stem cell transplantation on the risk of hepatic sinusoidal obstruction syndrome by Agrawal, Vaibhav, Ranganath, Praveen, Ervin, Kirsten D., Schmidt, Caitlin A., Cox, Elizabeth A., Nelson, Robert P., Schwartz, Jennifer E., Zaid, Mohammad Abu, Abonour, Rafat, Robertson, Michael J., Brinda, Bryan J., Griffin, Shawn P., Thakrar, Teresa C., Farag, Sherif S.

“…Sinusoidal obstruction syndrome (SOS) is a serious complication of hematopoietic stem cell transplantation (HSCT). Sirolimus plus tacrolimus is an accepted…”
Get full text

Practice parameter for the diagnosis and management of primary immunodeficiency by Bonilla, Francisco A, Bernstein, I Leonard, Khan, David A, Ballas, Zuhair K, Chinen, Javier, Frank, Michael M, Kobrynski, Lisa J, Levinson, Arnold I, Mazer, Bruce, Nelson, Jr, Robert P, Orange, Jordan S, Routes, John M, Shearer, William T, Sorensen, Ricardo U

Get more information

Pharmacokinetics of Subcutaneous IgPro20 in Patients with Primary Immunodeficiency by Wasserman, Richard L., Melamed, Isaac, Nelson, Robert P., Knutsen, Alan P., Fasano, Mary Beth, Stein, Mark R., Rojavin, Mikhail A., Church, Joseph A.

“…Background and Objectives: Immunoglobulin replacement is a standard therapy for patients with primary immunodeficiencies. Subcutaneous administration of…”
Get full text

Long-term efficacy, safety, and tolerability of Hizentra® for treatment of primary immunodeficiency disease by Jolles, Stephen, Borte, Michael, Nelson, Robert P, Rojavin, Mikhail, Bexon, Martin, Lawo, John-Philip, Wasserman, Richard L

“…Abstract Hizentra® (20% subcutaneous immunoglobulin [SCIG]) was administered to subjects with primary immunodeficiency disease in two extension studies in the…”
Get full text

Thymic Carcinoma: Outcomes After Surgical Resection by Okereke, Ikenna C., MD, Kesler, Kenneth A., MD, Freeman, Richard K., MD, Rieger, Karen M., MD, Birdas, Thomas J., MD, Ascioti, Anthony J., MD, Badve, Sunil, MD, FRCPath, Nelson, Robert P., MD, Loehrer, Patrick J., MD

“…Background Thymic carcinoma is a rare malignancy with little information regarding outcomes after therapy with curative intent. We undertook a retrospective…”
Get full text

Recent Advances in Transplantation for Primary Immune Deficiency Diseases: A Comprehensive Review by de la Morena, M. Teresa, Nelson, Robert P.

“…Hematopoietic cell transplantation (HCT) is a curative therapeutic option for severe combined immunodeficiency (SCID), a group of diseases which otherwise…”
Get full text

Molecular analysis of thymoma by Badve, Sunil, Goswami, Chirayu, Gökmen-Polar, Yesim, Nelson, Jr, Robert P, Henley, John, Miller, Nick, Zaheer, Narjis A, Sledge, Jr, George W, Li, Lang, Kesler, Kenneth A, Loehrer, Sr, Patrick J

“…Histologic classification of thymomas has significant limitations with respect to both subtype definitions and consistency. In order to better understand the…”
Get full text

Prognostic Indicators After Surgery for Thymoma by Okereke, Ikenna C., MD, Kesler, Kenneth A., MD, Morad, Mohamed H., MD, Mi, Deming, MD, Rieger, Karen M., MD, Birdas, Thomas J., MD, Badve, Sunil, MD, Henley, John D., MD, Turrentine, Mark W., MD, Nelson, Robert P., MD, Loehrer, Patrick J., MD

“…Background We undertook a 20-year retrospective institutional study to investigate prognostic indicators after surgery for thymoma. Methods From 1989 to 2009,…”
Get full text

Establishment and characterization of a novel cell line derived from human thymoma AB tumor by Gökmen-Polar, Yesim, Sanders, Kerry L, Goswami, Chirayu P, Cano, Oscar D, Zaheer, Narjis A, Jain, Rohit K, Kesler, Kenneth A, Nelson, Robert P, Vance, Gail H, Smith, Danielle, Li, Lang, Cardoso, Angelo A, Badve, Sunil, Loehrer, Patrick J, Sledge, George W

“…Thymomas are low-grade epithelial tumors of the anterior mediastinum. The complexity of the disease and the lack of in vitro and in vivo models hamper the…”
Get full text

An Integrative multi-lineage model of variation in leukopoiesis and acute myelogenous leukemia by Sarker, Joyatee M, Pearce, Serena M, Nelson, Jr, Robert P, Kinzer-Ursem, Tamara L, Umulis, David M, Rundell, Ann E

“…Acute myelogenous leukemia (AML) progresses uniquely in each patient. However, patients are typically treated with the same types of chemotherapy, despite…”
Get full text

Use of intravenous immunoglobulin in human disease: A review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology by Orange, Jordan S., Hossny, Elham M., Weiler, Catherine R., Ballow, Mark, Berger, Melvin, Bonilla, Francisco A., Buckley, Rebecca, Chinen, Javier, El-Gamal, Yehia, Mazer, Bruce D., Nelson, Robert P., Patel, Dhavalkumar D., Secord, Elizabeth, Sorensen, Ricardo U., Wasserman, Richard L., Cunningham-Rundles, Charlotte

“…Human immunoglobulin prepared for intravenous administration (IGIV) has a number of important uses in the treatment of disease. Some of these are in diseases…”
Get full text

Does Linezolid Cause Lactic Acidosis by Inhibiting Mitochondrial Protein Synthesis? by Hirano, Michio, Palenzuela, Lluis, Hahn, Noah M., Nelson, Robert P., Arno, Janet N., Schobert, Carol, Bethel, Robert, Ostrowski, Lisa A., Sharma, Manjuli R., Datta, Partha P., Agrawal, Rajendra K., Schwartz, Jennifer E.

“…Linezolid, an oxazolidinone antibiotic, inhibits bacterial protein synthesis by binding to 23S ribosomal RNA (rRNA). We studied 3 patients who experienced…”
Get full text

Cyclophosphamide/fludarabine nonmyeloablative allotransplant for acute myeloid leukemia by Khawaja, Muhammad Rizwan, Perkins, Susan M., Schwartz, Jennifer E., Robertson, Michael J., Kiel, Patrick J., Sayar, Hamid, Cox, Elizabeth A., Vance, Gail H., Farag, Sherif S., Cripe, Larry D., Nelson, Robert P.

“…We compared survival outcomes following myeloablative allotransplant (MAT) or cyclophosphamide/fludarabine (Cy/Flu) nonmyeloablative allotransplant (NMAT) for…”
Get full text

26. Immunomodulation and immunotherapy: Drugs, cytokines, cytokine receptors, and antibodies by Nelson, Robert P., Ballow, Mark

“…The preceding chapters in this primer have provided an overview of the immune response that serves as a background for understanding potential sites for immune…”
Get full text

Rituximab for the Treatment of Thymoma-Associated and De Novo Myasthenia Gravis: 3 Cases and Review by Nelson, Robert P, Pascuzzi, Robert M, Kessler, Kenneth, Walsh, Laurence E, Faught, Phillip P, Ramanuja, Srinivasan, Pescovitz, Mark D, Loehrer, Patrick J

“…OBJECTIVES:Myasthenia gravis (MG) is an immune-mediated disorder associated with autoantibodies against postsynaptic nicotinic acetylcholine receptors at…”
Get full text

Immune-Mediated Diseases and Immunodeficiencies Associated with Thymic Epithelial Neoplasms by Khawaja, Muhammad Rizwan, Nelson, Robert P., Miller, Nicholas, Badve, Sunil S., Loehrer, Elizabeth, Czader, Magdalena, Perkins, Susan M., Kesler, Kenneth, Loehrer, Patrick J.

“…Introduction This retrospective study aimed to characterize the clinical hematological and immunological features of patients with thymic epithelial neoplasms…”
Get full text

Bacterial meningitis and inflammation by Nelson, Jr, Robert P

“…Bacterial meningitis is a condition in which inflammation plays a role in disease resolution and also contributes to morbidity. Markers of inflammation may be…”
Get full text

Desensitization to imatinib in patients with leukemia by Nelson, Jr, Robert P, Cornetta, Kenneth, Ward, Kelly E, Ramanuja, Srinivasan, Fausel, Chris, Cripe, Larry D

“…Imatinib mesylate is a tyrosine kinase inhibitor used for the treatment of chronic myeloid leukemia and hypereosinophilic syndrome. Imatinib is associated with…”
Get more information

Opportunistic infections in a patient with HIV and thymoma by Leathers, Carrie A., MD, Azar, Marwan M., MD, Badve, Sunil S., MD, Roth, Trenton D., MD, Loehrer, Patrick J., MD, Nelson, Robert P., MD

“…Laboratory analysis was notable for hyponatremia, hypochloremia, elevated blood urea nitrogen and creatinine, mildly elevated transaminases, hypoalbuminemia,…”
Get full text